Evidence map›Paper›PMID 32864441›Full record

ArticleLaryngoscope investigative otolaryngology2020

Preoperative evaluation and treatment consideration of parotid gland tumors.

Katri Aro, Jarkko Korpi, Jussi Tarkkanen, Antti Mäkitie, Timo Atula

Abstract read
In one paragraph

Article in Laryngoscope investigative otolaryngology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katri AroDepartment of Otorhinolaryngology-Head and Neck Surgery University of Helsinki and Helsinki University Hospital Helsinki Finland.ORCID https://orcid.org/0000-0001-8103-5237
Jarkko KorpiDepartment of Otorhinolaryngology-Head and Neck Surgery University of Helsinki and Helsinki University Hospital Helsinki Finland.ORCID https://orcid.org/0000-0002-5057-2379
Jussi TarkkanenDepartment of Pathology HUSLAB, University of Helsinki and Helsinki University Hospital Helsinki Finland.ORCID https://orcid.org/0000-0002-5807-1085
Antti MäkitieDepartment of Otorhinolaryngology-Head and Neck Surgery University of Helsinki and Helsinki University Hospital Helsinki Finland.ORCID https://orcid.org/0000-0002-0451-2404
Timo AtulaDepartment of Otorhinolaryngology-Head and Neck Surgery University of Helsinki and Helsinki University Hospital Helsinki Finland.ORCID https://orcid.org/0000-0002-6560-1128

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe nature of parotid tumors often remains unknown preoperatively and final histopathology may reveal unexpected malignancy. Still, the use of fine-needle aspiration cytology (FNAC) and imaging varies in the management of these tumors.

methodsWe evaluated the preoperative examinations and management of all 195 parotid gland tumors diagnosed within our catchment area of 1.6 million people during 2015.

resultsAltogether 171 (88%) tumors were classified as true salivary gland neoplasms. FNAC showed no false malignant findings, but it was false benign in 5 (2.6%) cases. Preoperative MRI was utilized in 48 patients (25%). Twenty (10%) malignancies included 16 salivary gland carcinomas. Pleomorphic adenomas accounted for 52% of all adenomas. For 24 (40%) Warthin tumors, surgery was omitted.

conclusionThe proportion of malignancies was lower than generally presented. Our proposed guidelines include ultrasound-guided FNAC with certain limitations. MRI is warranted in selected cases, but seems unnecessary routinely.

Indexed as

cytologydiagnosisfine‐needle aspirationsalivary glandsurgery

Identifiers

PMID32864441
PMCPMC7444776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.